Health products policy and standards
Our team provides authoritative guidance and standards on quality, safety and efficacy of health products and supports countries to formulate evidence-based policies and ensure good practice throughout the value chain.
Expert Committees
Advisory groups
Databases
Publications
All →
12 November 2025
Development of medical device policies, 2nd ed.
A first edition of the Development of Medical Devices Policies was published in 2011. This second edition was prepared to reflect the transition from the...
6 October 2025
Improving access to assistive technology in United Republic of Tanzania (2022-2023): project report
The report summarizes a collaboration between the Ministry of Health of the United Republic of Tanzania, HelpAge Tanzania and the World Health Organization...
5 October 2025
Enabling rapid access to essential assistive technology in Ukraine (2022-2023): project report
This report summarizes a collaboration between the Ministry of Health of Ukraine and the World Health Organization (WHO) in 2022 and 2023. The goal was...
3 October 2025
WHO Drug Information - Volume 39, No. 3
The Third issue of volume 39 for 2025 includes:Consultation Documents: Cefiderocol sulfate tosilate (cefiderocoli sulfas tosilatum) Cefiderocol powder...
Journal articles
Evolution of Ebola and Marburg Treatment Centers Design, a Review of the Last Ten Years of Outbreaks in Africa
Architecture 2024, 4(4), 930-947
Disease foci of pharmaceutical research and development as reflected in applications for International Nonproprietary Names, 1953–2022
Bulletin of the World Health Organization, Volume 103, Number 1, January 2025 1-80
WHO-listed authorities (WLA) framework: transparent evidence-based approach for promoting regulatory reliance towards increased access to quality-assured medical products
Frontiers in Medicine, 23 September 2024 Sec. Regulatory Science